| Clinical Orthopaedics and Related Research |
| © The Association of Bone and Joint Surgeons 2008 |
| 10.1007/s11999-008-0163-1 |
M. I. Safa Kapicioglu1
and Feza Korkusuz2 
| (1) | Department of Orthopedic Surgery and Traumatology, Faculty of Medicine, Selcuk University, Meram, 42080 Konya, Turkey |
| (2) | Department of Physical Education and Sports, and Medical Center, Middle East Technical University, Ankara, 06531, Turkey |
![]() |
M. I. Safa Kapicioglu (Corresponding author) Email: safa.kapicioglu@gmail.com |
![]() |
Feza Korkusuz Email: feza@metu.edu.tr |
Received: 8 June 2007 Accepted: 25 January 2008 Published online: 15 February 2008
Diagnosis of developmental dysplasia of the hip (DDH) is crucial in fast-growing underdeveloped communities with the tradition of swaddling [11]. Early diagnosis of the disease relies mostly on physical examination by experienced health care professionals and ultrasound screening of the hip with proper probes. Primary care physicians working in rural places lack the knowledge on DDH examination [24] and the availability of an experienced health care professional certified for ultrasound screening is typically unavailable. Late onset of DDH is not rare [21] and screening should cover followup examinations until the child is walking [4]. A noninvasive, simple, and inexpensive device that can be used by inexperienced midwives, obstetricians, and primary care and family physicians in field practice and at periodic examinations for the screening of DDH would therefore be useful.
In vivo assessment of mechanical properties of bones [1, 20, 25] and joints [3, 9, 10, 12, 23] by vibration and sound propagation analysis is not new. Mollan et al. [18] and McCoy et al. [16] described the advantages of the use of vibration sensors to detect acoustic signals passing through joints. Sensitivity and objectivity were the advantages of this non-invasive method. In 1987, Stone et al. [23] described a two-part clinical trial for diagnosing DDH based on the attenuation of sound transmission across the hip using a stethoscope and a 256-Hz medical tuning fork. However, they used only a single frequency sound generated by the medical tuning fork and a qualitative signal detection method. Chu et al. [3] used microphones to record sound transmission and later subtract the background noises in tissues. However, they did not evaluate sound transmission through joints. Kwong et al. [13] developed an acoustic device and examined 16 patients with unilateral DDH. Using the center of the sacrum for excitation of the vibration force they were able to record structural asymmetry between normal and dysplastic hips.
We describe a broadband electroacoustic generator combined with a receiver (microphone)—a so-called sonospectrography system entirely different than ultrasound. We then asked if sound transmission differs between normal and dysplastic hips by quantitative measurement at four knee and hip positions. Second, we asked which knee and hip position presents the largest difference of sound transmission between normal and dysplastic hips. Finally, we asked if sound transmission would diminish with age in normal and dysplastic hips.
We recruited 22 patients, 19 girls and 3 boys, with an average age of 5.9 ± 4.3 years (range, 0.3–14 years) radiographically diagnosed with unilaterally dislocated hips and examined each hip in all patients using sonospectrography. The normal hip served as the control for the dysplastic hip. We examined the hips in four positions and compared the amplitude of the signals at different frequencies. Information on the study was given and a written consent for participation in examination procedures and surgical and/or nonsurgical treatments was obtained from the patients’ parents.
The reception and recording channel consists of a broadband and sensitive semiconductor microphone, microphone preamplifier, and a sound energy computing integration system. The microphone is isolated for prevention of external noise by a special sound insulator. Received, measured, and computed sound data are recorded as a function of amplitude and frequency (spectrum) by two means of a two-channel analog recorder. Excitation and recording of sound was conducted at the 200 Hz to 2.5 KHz range throughout the experiments. The frequency scanning time for a complete sound spectrum measurement lasted about 3 seconds. The amplitude was expressed as percentage, as a function of frequency. The developed system was fully automatic allowing its use and application by unskilled healthcare professionals.
We performed paired t-tests to detect differences in signal amplitude between the dysplastic and normal hip sound transmission scores at the four positions. We then employed a one-way within subject analysis of variance (ANOVA) using Bonferroni posthoc testing for multiple comparison to determine differences between positions. Hotelling’s trace value (5.097) was obtained using SPSS, v.11 (SPSS Inc, Chicago, IL), with significance value (0.000) in order to control reliability of results. We tested the null hypothesis that the error covariance matrix of the orthonormalized transformed dependent variables was proportional to an identity matrix. The criteria used for this hypothesis was Greenhouse-Geisser with a value of 0.81 which was called as a test of sphericity. Finally, correlations were calculated between age and sound transmission scores. Throughout the analysis, significance level was set to equal 0.05.
|
Hip position |
Normal hips (Mean ± StDev) |
Dysplastic hips (Mean ± StDev) |
Difference between normal and dysplastic hips (Mean ± StDev) |
p |
|---|---|---|---|---|
|
1 |
17.7 ± 10.4 |
8.3 ± 5.4 |
9.4 ± 6.9 |
0.000 |
|
2 |
34.7 ± 18.1 |
13.5 ± 9.7 |
20.1 ± 15.8 |
0.000 |
|
3 |
35.3 ± 21.9 |
13.2 ± 12.0 |
22.1 ± 15.2 |
0.000 |
|
4 |
88.8 ± 30.2 |
22.2 ± 11.5 |
66.6 ± 28.8 |
0.000 |
|
Knee and hip position |
Knee and hip positions compared |
Sound transmission mean value difference (Hz) |
p Value* |
|---|---|---|---|
|
1 |
2 |
−11.5* |
0.004 |
|
3 |
−12.7* |
0.022 |
|
|
4 |
−57.2* |
0.000 |
|
|
2 |
1 |
11.5* |
0.004 |
|
3 |
−1.3 |
1.000 |
|
|
4 |
−45.7* |
0.000 |
|
|
3 |
1 |
12.7* |
0.022 |
|
2 |
1.3 |
1.000 |
|
|
4 |
−44.5* |
0.000 |
|
|
4 |
1 |
57.2* |
0.000 |
|
2 |
45.7* |
0.000 |
|
|
3 |
44.5* |
0.000 |
The effectiveness of clinical and ultrasonic screening of DDH remains controversial [5] as late onset of the disease is not rare [21] and evidence is lacking either for [6] or against ultrasound screening [4, 27]. A sonospectrographic device was developed to noninvasively diagnose unilateral DDH at four different hip positions. The device, which is entirely different than ultrasound, is portable, inexpensive and easy to use at initial and/or followup examinations.
Sonospectographic measurements are simple, reliable and straightforward. There is no need for additional calculations and reporting after the measurements. Quantification of physical examination using sonospectrography is the advantage of this system. Further studies are essential to assess its effectiveness and reliability in comparison with ultrasonography. Our data suggest the sonospectrography system can detect DDH in patients between 4 months and 14 years of age. We observed three moderate and one intense resonance peak in all patients, which is similar to a typical vibration transmission pattern of the skeletal tissue. Of these four resonance peaks, the third and most intense resonance peak was recorded at about 410 Hz and the last between 600 Hz and 800 Hz. The last resonance peak was not detected in all cases. The sound transmission mean values were higher at Position 4 compared to other positions. Comparing sides in individual patients, the highest amplitude difference between the normal hip and the DDH hip was observed at the same position. Although the number of measured patients was limited, measurement of the normal hip and the pathological DDH in the same patient increased the importance of the findings. Sound transmission values decreased as age increased. In older patients plain radiography can be used for diagnosis.
Our data suggest this novel electroacoustic sound excitation device—the sonospectrography system—effectively measured transmission and absorption spectrum of small amplitude sound waves in normal and DDH joints. Our device is distinct from that used in accelerometer studies [17, 18, 26] in that we did not measure or evaluate finite high-amplitude wave transmission using principles of nonlinear wave mechanics. Further, the sonospectrography system was built to be portable and to work with a battery.
We were able to effectively use the sonospectrography system to diagnose unilateral DDH in older children. Flexing the hip from neutral position caused an increase in amplitude recording. Early studies [22, 23] used similar techniques; these studies highlighted interobserver variability of the method and difficulty in screening bilateral DDH. Evaluations in these studies, however, were qualitative and subjective. We used acoustic waves received by the microphone and made and analyzed quantitative recordings. A commercially available mechanical vibration excitation device was used for the screening of unilateral DDH recently [12, 13]. In those experiments, the exciter and two microphones were separately placed on the posterior of the sacrum and over the greater trochanters, respectively. Measurements were furthermore made at the frequency range of 200 to 315 Hz. Acoustic vibration transmission measurements were made in single neutral hip positions in these studies. Our study differs from those studies by (1) exciting the hip at 4 different positions; (2) using the patella and ASIS for excitation and recording, respectively; and (3) generating sound at the 20 Hz to 2.5 KHz frequency range. The sonospectrography device developed and used in this study is a totally different device than the ultrasound that is used to screen the hip directly. In ultrasonic screening the sound wave is reflected from the musculoskeletal tissues constructing the hip. The sonospectrography device measures sound transmission through the tissues. In other words, transmission instead of reflection of sound from tissues is recorded in the later system.
The sonospectrography device is portable and can be used with battery power. Incidence of DDH will remain high in the future [2, 7, 8] and screening is essential until the child is walking [21]. The first step in the diagnosis of DDH from birth to about 6 weeks of age is physical examination [19]. Although Ortolani and Barlow tests have been used effectively as physical tests, the incidence of missed diagnoses of DDH has not decreased; on the contrary, it has increased in some centers [15, 19]. We, therefore, propose exploring the sonospectrography device for use in the field by primary healthcare professionals for the diagnosis of unilateral DDH. As sound transmission values of dysplastic hips are lower than normal hips, a database may be developed in the near future for normal and dysplastic hips to aid the early diagnosis of bilateral DDH as well. The sonospectrography device is inexpensive; developing the device can cost less than $5000.
For the purpose of diagnosis, the interpretation of sounds in the musculoskeletal system is relatively new. Vibration arthrography depends on the sounds elicited by moving joints, most often the knee and neonatal hip, and detected by surface transducers [11, 14, 17, 26]. Systems have been developed [12] and used [10] for the measurement of transmission properties of acoustic waves in the hip.
The sonospectrography system is a practical, novel, and noninvasive method that appears to reliably detect DDH in older children. Hip and knee flexion during sonospectrography examination increases wave propagation in normal and dislocated hips; the former being more obvious, and amplitudes decreased as age increased. We believe the system might be useful for screening newborns with dysplasia and without subluxation or dislocation, but reliability, sensitivity, and specificity will need to be established in these patients.